A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100

OBJECTIVE: Insulin icodec is a novel once-weekly basal insulin analog. This trial investigated the efficacy and safety of icodec using different once-weekly titration algorithms. RESEARCH DESIGN AND METHODS: This was a phase 2, randomized, open-label, 16-week, treat-to-target study. Insulin-naive ad...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Diabetes Care
Autori principali: Lingvay, Ildiko, Buse, John B., Franek, Edward, Hansen, Melissa V., Koefoed, Mette M., Mathieu, Chantal, Pettus, Jeremy, Stachlewska, Karolina, Rosenstock, Julio
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Diabetes Association 2021
Soggetti:
Emerging Therapies: Drugs and Regimens
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8323172/
https://ncbi.nlm.nih.gov/pubmed/33875484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc20-2878
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi